These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30090793)

  • 21. Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
    Teschke R; Eickhoff A; Schulze J
    J Clin Transl Hepatol; 2013 Sep; 1(1):59-74. PubMed ID: 26357608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation.
    Meunier L; Larrey D
    Front Pharmacol; 2019; 10():1482. PubMed ID: 31920666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-Induced Liver Injury: Highlights of the Recent Literature.
    Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
    Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible increase in liver enzymes due to amlodipine: A case report.
    Varghese G; Madi L; Ghannam M; Saad R
    SAGE Open Med Case Rep; 2020; 8():2050313X20917822. PubMed ID: 32637107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing Scenario.
    Colaci CS; Mendizabal M; Bessone F
    Curr Drug Saf; 2019; 14(2):94-101. PubMed ID: 30767751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Induced Liver Injury Attributed to a Curcumin Supplement.
    Imam Z; Khasawneh M; Jomaa D; Iftikhar H; Sayedahmad Z
    Case Rep Gastrointest Med; 2019; 2019():6029403. PubMed ID: 31781418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
    García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
    J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
    Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
    Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobramycin-induced hepatotoxicity.
    Nisly SA; Ray SM; Moye RA
    Ann Pharmacother; 2007 Dec; 41(12):2061-5. PubMed ID: 17956959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyproterone Acetate-Induced Acute Liver Failure: A Case Report and Review of the Literature.
    Kumar P; Reddy S; Kulkarni A; Sharma M; Rao PN
    J Clin Exp Hepatol; 2021; 11(6):739-741. PubMed ID: 34866850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Devarbhavi H; Raj S; Aradya VH; Rangegowda VT; Veeranna GP; Singh R; Reddy V; Patil M
    Hepatology; 2016 Mar; 63(3):993-9. PubMed ID: 26439084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
    Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
    Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.
    Jing J; Teschke R
    J Clin Transl Hepatol; 2018 Mar; 6(1):57-68. PubMed ID: 29577033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced severe liver injury due to
    Zhu L; Geng J; Xiao A
    J Biomed Res; 2022 May; 36(3):215-220. PubMed ID: 35965441
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced liver injury as predominant cause of acute liver failure in a monocenter study].
    Bechmann LP; Manka P; Best J; Saner FH; Paul A; Canbay A; Gerken G
    Dtsch Med Wochenschr; 2014 May; 139(17):878-82. PubMed ID: 24760689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.
    Lo Re V; Carbonari DM; Lewis JD; Forde KA; Goldberg DS; Reddy KR; Haynes K; Roy JA; Sha D; Marks AR; Schneider JL; Strom BL; Corley DA
    Am J Med; 2016 Mar; 129(3):283-91.e5. PubMed ID: 26597673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.